• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼科医生对中重度干眼治疗的看法:一项医生调查的结果。

Ophthalmologist perceptions regarding treatment of moderate-to-severe dry eye: results of a physician survey.

机构信息

Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY, USA.

出版信息

Eye Contact Lens. 2010 Jan;36(1):33-8. doi: 10.1097/ICL.0b013e3181c739ad.

DOI:10.1097/ICL.0b013e3181c739ad
PMID:20009946
Abstract

PURPOSE

To understand ophthalmologists' current perceptions and treatment of patients with moderate-to-severe dry eye disease (DED).

SETTING

Online survey.

METHODS

The online survey was sent to 7,882 ophthalmologists, including 51 corneal specialists, throughout the United States from October 9 to 21, 2008. The response rate was 3.1% (n = 245), typical for this type of survey. Only ophthalmologists who treated four or more moderate-to-severe DED patients per month (235 of 245 [96%]) were asked to complete the survey.

RESULTS

Ninety-four percent of respondents agreed that more treatment options are needed for moderate-to-severe DED. Corneal specialists were more likely to strongly agree (63%) than general ophthalmologists (54%). Only 33% overall felt that current therapies were extremely or very effective for moderate DED and only 5% for severe disease. Ninety-two percent agreed that multiple therapeutic agents are needed to manage moderate-to-severe DED. The respondents prescribed or recommended a mean of 3.2 different treatments (standard deviation = 1.2) for moderate DED patients over the course of a year and 4.9 (standard deviation = 2.2) for patients with severe DED. The most highly ranked goals for treatment of moderate-to-severe DED patients were maintaining and protecting the ocular surface (ranked 1 or 2 x 74%) and lubricating and hydrating the ocular surface (ranked 1 or 2 x 67%). Corneal specialists ranked maintaining and protecting the ocular surface even more highly (ranked 1 or 2 x 82%).

CONCLUSIONS

Results reflected the difficulty of treating moderate-to-severe DED, the importance of using multiple treatment approaches, the limitations of current treatment options, and the need for additional treatment options.

摘要

目的

了解眼科医生对中重度干眼(DED)患者的当前认知和治疗方法。

背景

这是一项在线调查。

方法

该在线调查于 2008 年 10 月 9 日至 21 日向全美 7882 名眼科医生发送,其中包括 51 名角膜专家。回复率为 3.1%(n=245),这种类型的调查属于典型回复率。只有每月治疗 4 例或以上中重度 DED 患者的眼科医生(245 例中的 235 例[96%])被要求完成调查。

结果

94%的受访者同意中重度 DED 需要更多的治疗选择。角膜专家比普通眼科医生(分别为 63%和 54%)更有可能强烈同意这一观点。总体而言,只有 33%的人认为目前的治疗方法对中度 DED 非常有效,而只有 5%的人认为对重度疾病有效。92%的人同意需要多种治疗药物来治疗中重度 DED。受访者在一年中为中度 DED 患者平均开了或建议开 3.2 种不同的治疗药物(标准差=1.2),为重度 DED 患者开了 4.9 种(标准差=2.2)。治疗中重度 DED 患者的首要目标是维持和保护眼表(74%的受访者将其列为第 1 或第 2 位)和润滑和保湿眼表(67%的受访者将其列为第 1 或第 2 位)。角膜专家甚至将维持和保护眼表列为更重要的目标(82%的受访者将其列为第 1 或第 2 位)。

结论

研究结果反映了治疗中重度 DED 的困难,使用多种治疗方法的重要性,当前治疗选择的局限性,以及对额外治疗选择的需求。

相似文献

1
Ophthalmologist perceptions regarding treatment of moderate-to-severe dry eye: results of a physician survey.眼科医生对中重度干眼治疗的看法:一项医生调查的结果。
Eye Contact Lens. 2010 Jan;36(1):33-8. doi: 10.1097/ICL.0b013e3181c739ad.
2
Ophthalmologist perceptions regarding treatment of moderate to severe dry eye: results of a physician survey.眼科医生对中重度干眼症治疗的看法:一项医生调查的结果
Trans Am Ophthalmol Soc. 2009 Dec;107:205-10.
3
Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease.医生治疗实践与国际干眼疾病诊断和治疗工作组指南的一致性。
Cornea. 2007 Apr;26(3):284-9. doi: 10.1097/ICO.0b013e31802dffc7.
4
Utility assessment among patients with dry eye disease.干眼症患者的效用评估
Ophthalmology. 2003 Jul;110(7):1412-9. doi: 10.1016/S0161-6420(03)00462-7.
5
Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.政策与实践:医疗和教育环境中处方治疗与耐用医疗设备的比较
Pediatrics. 2004 Nov;114(5):e612-25. doi: 10.1542/peds.2004-1063.
6
Survey of ophthalmologists about ocular toxoplasmosis.
Am J Ophthalmol. 2005 Oct;140(4):724-6. doi: 10.1016/j.ajo.2005.04.048.
7
Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.长期佩戴型硅水凝胶软性接触镜用于治疗移植物抗宿主病继发的中度至重度干眼体征和症状。
Eye Contact Lens. 2007 May;33(3):144-7. doi: 10.1097/01.icl.0000244154.76214.2d.
8
Microbial keratitis in Thailand: a survey of common practice patterns.泰国的微生物性角膜炎:常见诊疗模式调查
J Med Assoc Thai. 2008 Mar;91(3):316-22.
9
Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative.医生对女性冠心病风险预防的认知水平及障碍:女性与心脏病医生教育倡议的调查结果
Womens Health Issues. 2007 Mar-Apr;17(2):93-100. doi: 10.1016/j.whi.2006.11.003.
10
Attitudes towards diagnostic tests and therapies for dry eye disease.干眼疾病诊断测试和治疗方法的态度。
Ophthalmic Res. 2010;43(1):11-7. doi: 10.1159/000246573. Epub 2009 Oct 14.

引用本文的文献

1
Overview of CFTR activators and their recent studies for dry eye disease: a review.囊性纤维化跨膜传导调节因子激活剂及其治疗干眼病的最新研究综述
RSC Med Chem. 2023 Sep 25;14(12):2459-2472. doi: 10.1039/d3md00448a. eCollection 2023 Dec 13.
2
Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease.提高溶解度的合成策略:新型吡唑并[1,5-a]嘧啶 CFTR 激活剂的优化,可改善干眼症。
J Med Chem. 2023 Jan 12;66(1):413-434. doi: 10.1021/acs.jmedchem.2c01382. Epub 2022 Dec 26.
3
Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice.
新型 CFTR 激活剂 Cact-3 可改善东莨菪碱诱导的干眼模型小鼠的眼表面功能障碍。
Int J Mol Sci. 2022 May 6;23(9):5206. doi: 10.3390/ijms23095206.
4
Title: P2x7 Receptor Activation and Estrogen Status Drive Neuroinflammatory Mechanisms in a Rat Model for Dry Eye.标题:P2X7受体激活与雌激素状态驱动干眼症大鼠模型中的神经炎症机制
Front Pharmacol. 2022 Apr 5;13:827244. doi: 10.3389/fphar.2022.827244. eCollection 2022.
5
Comparing the needs and preferences of patients with moderate and severe dry eye symptoms across four countries.比较四个国家中患有中度和重度干眼症状患者的需求和偏好。
BMJ Open Ophthalmol. 2019 Dec 15;4(1):e000360. doi: 10.1136/bmjophth-2019-000360. eCollection 2019.
6
Defining the needs and preferences of patients with dry eye disease.明确干眼症患者的需求和偏好。
BMJ Open Ophthalmol. 2019 Dec 5;4(1):e000315. doi: 10.1136/bmjophth-2019-000315. eCollection 2019.
7
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies.0.1%环孢素 A 阳离子乳剂治疗干眼的疗效和安全性:两项双盲、随机、对照的 III 期临床研究的汇总分析。
Br J Ophthalmol. 2019 Jan;103(1):125-131. doi: 10.1136/bjophthalmol-2017-311801. Epub 2018 Mar 15.
8
Survey of Ophthalmologists Regarding Practice Patterns for Dry Eye and Sjogren Syndrome.眼科医生关于干眼症和干燥综合征诊疗模式的调查
Eye Contact Lens. 2018 Nov;44 Suppl 2(Suppl 2):S196-S201. doi: 10.1097/ICL.0000000000000448.
9
The Prospective Health Assessment of Cataract Patients' Ocular Surface (PHACO) study: the effect of dry eye.白内障患者眼表的前瞻性健康评估(PHACO)研究:干眼的影响
Clin Ophthalmol. 2017 Aug 7;11:1423-1430. doi: 10.2147/OPTH.S120159. eCollection 2017.
10
TFOS DEWS II pain and sensation report.TFOS DEWS II 干眼综合征相关眼部不适和眼表面感觉报告。
Ocul Surf. 2017 Jul;15(3):404-437. doi: 10.1016/j.jtos.2017.05.002. Epub 2017 Jul 20.